PFE Stock Recent News
PFE LATEST HEADLINES
Pfizer Inc. PFE will release earnings results for the second quarter before the opening bell on Tuesday, Aug. 5.
In a market filled with volatility that seems less and less reliant on fundamentals with each passing day, risk-adverse investors may be better off looking for stocks that generate reliable streams of passive income.
We'll see another busy week for earnings , with reports also coming from BioNTech, GlobalFoundries, Rivia, Occidental, and many more.
Once a market darling during the early pandemic years, Pfizer (PFE 0.84%) has been on a straight southbound path for several years now. The company's shares are down by 50% since 2022.
Pfizer (NYSE:PFE) is set to announce its earnings on Tuesday, August 5, 2025, prior to the market opening. Analyzing Pfizer's stock performance over the previous five years after earnings announcements indicates a trend towards positive movement.
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents at London's Court of Appeal.
Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.
PFE eyes Q2 earnings beat as strength in Vyndaqel and Padcev is expected to offset declines from Eliquis, Ibrance and Prevnar.
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing globally, the future of gene therapy, changes at FDA, and more.
CNBC's Joe Kernen reports on the latest news.